Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

A new therapy sped up wound healing and reduced scarring in diabetic rats.

Two patients with stubborn hair loss grew hair after PDRN injections.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

34% of patients on hepatitis C treatment had reversible skin issues.

CD2 might be a new treatment target for patchy alopecia areata.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Astragaloside A may help fight lung cancer by targeting specific proteins.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Baricitinib and ritlecitinib are both effective and safe for treating severe alopecia areata.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.